EPISODE · Jan 29, 2010 · 11 MIN
Podcast 72: A conversation about two new drugs for multiple sclerosis.
from Clinical Conversations · host NEJM Group
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease. Interview-story link: MS Treatments Said to Offer ‘New Horizon’ News links: New York Times series on radiation safety Lancet study on glycated hemoglobin levels FDA approval of diabetes drug JNCI study on ovarian cancer symptoms The post Podcast 72: A conversation about two new drugs for multiple sclerosis. first appeared on Clinical Conversations.
Embed this episode
What this episode covers
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease. Interview-story link: MS Treatments Said […]
NOW PLAYING
Podcast 72: A conversation about two new drugs for multiple sclerosis.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.